An adenoviral vector cancer vaccine that delivers a tumor-associated antigen/CD40-ligand fusion protein to dendritic cells

di Zhang, Lixin, Tang, Yucheng, Akbulut, Hakan, Zelterman, Daniel, Linton, Phyllis-Jean, Deisseroth, Albert B.
Pubblicazione 2003

Vaccination of Rabbits with an Adenovirus Vector Expressing the Papillomavirus E2 Protein Leads to Clearance of Papillomas and Infection

di Brandsma, Janet L., Shlyankevich, Mark, Zhang, Lixin, Slade, Martin D., Goodwin, Edward C., Peh, Woei, Deisseroth, Albert B.
Pubblicazione 2004

EBNA1 regulates cellular gene expression by binding cellular promoters

di Canaan, Allon, Haviv, Izhak, Urban, Alexander E., Schulz, Vincent P., Hartman, Steve, Zhang, Zhengdong, Palejev, Dean, Deisseroth, Albert B., Lacy, Jill, Snyder, Michael, Gerstein, Mark, Weissman, Sherman M.
Pubblicazione 2009

Differentiation syndrome with ivosidenib and enasidenib treatment in patients with relapsed or refractory IDH-mutated AML: a U.S. Food and Drug Administration systematic analysis

di Norsworthy, Kelly J., Mulkey, Flora, Scott, Emma C., Ward, Ashley F., Przepiorka, Donna, Charlab, Rosane, Dorff, Sarah, Deisseroth, Albert B., Kazandjian, Dickran, Sridhara, Rajeshwari, Beaver, Julia A., Farrell, Ann T., de Claro, R. Angelo, Pazdur, Richard
Pubblicato in Clin Cancer Res (2020)